¹û¶³´«Ã½

Anti-trust issues stymie Syngenta deal

Syngenta has rebuffed Monsanto for a second time, but now Germany's BASF could be in the frame.

Pre-emption pays for Hunting

Hunting reacted swiftly to the fall-away in crude prices and the group's share price has been bolstered by its pre-emption.

RPC integrating and growing

RPC continues to drive growth both organically and through acquisition

Ithaca profitable at $10 a barrel

Ithaca has weathered the fall in Brent crude, but a heavy discount on the stock market suggests investors are still wary of North Sea operators

Schlumberger boost for Horse Hill

The Horse Hill licences are back in the news again following positive analysis by Schlumberger

News & Tips: Creston, WYG, Gemfields & more...

Shares in Japan fall as the yen strengthens and investors continue to focus on the prospect of the US Fed trimming interest rates, while Chinese shares slip after weak inflation data.

4D Pharma nears human trials

A year on from its IPO, 4D Pharma is poised to launch its first clinical trials on humans

The boys from the black stuff

COMMODITIES: Some think that Opec delegates seeking assurances on near-term Saudi Arabian production cuts are in for a crude response, as divisions over the current quota strategy intensify

Chart of the day: Japan stuck in neutral

There's no doubt that Abenomics delivered an initial jolt to Japan's financial markets, but the desired long-term effects on domestic industry may prove more elusive.

No smoke without ire for BATS

A non-executive of tobacco giant British American Tobacco has shown more faith in the group than Canadian smokers.